|
PTPN11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54550000000176E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.414600E-04 |
| Normal-vs-Stage2 |
2.505800E-02 |
| Normal-vs-Stage3 |
4.88639999995932E-06 |
| Normal-vs-Stage4 |
1.95763999999432E-05 |
| Stage1-vs-Stage2 |
3.738400E-01 |
| Stage1-vs-Stage3 |
2.013600E-01 |
| Stage1-vs-Stage4 |
2.195400E-01 |
| Stage2-vs-Stage3 |
8.262400E-02 |
| Stage2-vs-Stage4 |
7.342000E-02 |
| Stage3-vs-Stage4 |
8.033400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82072000000089E-05 |
| Normal-vs-AfricanAmerican |
1.122000E-01 |
| Normal-vs-Asian |
1.041590E-03 |
| Caucasian-vs-AfricanAmerican |
1.662050E-01 |
| Caucasian-vs-Asian |
8.190400E-01 |
| AfricanAmerican-vs-Asian |
2.744400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47230000002718E-06 |
| Normal-vs-Female |
1.846070E-04 |
| Male-vs-Female |
1.727970E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.791300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.74140000000134E-05 |
| Normal-vs-Age(61-80Yrs) |
1.397710E-04 |
| Normal-vs-Age(81-100Yrs) |
2.010000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.854000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.494200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.999000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.584800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.104200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.586400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.013600E-01 |
| Classical-VS-Follicular |
6.982000E-01 |
| Classical-VS-Other |
1.058780E-01 |
| Classical-VS-Normal |
3.028000E-04 |
| Tall-VS-Follicular |
3.487000E-01 |
| Tall-VS-Other |
2.974400E-01 |
| Tall-VS-Normal |
2.773000E-04 |
| Follicular-VS-Other |
2.185600E-01 |
| Follicular-VS-Normal |
2.275900E-03 |
| Other-VS-Normal |
2.437800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.42640000000161E-05 |
| Normal-vs-N1 |
4.09399999999893E-05 |
| N0-vs-N1 |
3.705000E-01 |
|
|
